The report offers detailed coverage of Anti-Obesity Prescription Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Anti-Obesity Prescription Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle such as intake of drugs due to stress, alcohol leads to growing demand for obesity management resulting in growth of this trend.
The report forecast global Anti-Obesity Prescription Drugs market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2023-2028.
First, this report covers the present status and the future prospects of the global Anti-Obesity Prescription Drugs market for 2018-2028.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Anti-Obesity Prescription Drugs according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows: By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme
Market by Order Type
Orlistat
Phentermine and Topiramate
Bupropion and Naltrexone
Lorcaserin
Liraglutide
Market by Application
Pediatric
Adult
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Type (2020-2025)
1.3.2 Orlistat
1.3.3 Phentermine and Topiramate
1.3.4 Bupropion and Naltrexone
1.3.5 Lorcaserin
1.3.6 Liraglutide
1.4 Market Segment by Application
1.4.1 Global Anti-Obesity Prescription Drugs Market Share by Application (2020-2025)
1.4.2 Pediatric
1.4.3 Adult
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Obesity Prescription Drugs Market Size
2.1.1 Global Anti-Obesity Prescription Drugs Revenue 2015-2025
2.1.2 Global Anti-Obesity Prescription Drugs Sales 2015-2025
2.2 Anti-Obesity Prescription Drugs Growth Rate by Regions
2.2.1 Global Anti-Obesity Prescription Drugs Sales by Regions 2015-2019
2.2.2 Global Anti-Obesity Prescription Drugs Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-Obesity Prescription Drugs Sales by Manufacturers
3.1.1 Anti-Obesity Prescription Drugs Sales by Manufacturers 2015-2019
3.1.2 Anti-Obesity Prescription Drugs Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Anti-Obesity Prescription Drugs Revenue by Manufacturers (2015-2019)
3.2.2 Anti-Obesity Prescription Drugs Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Anti-Obesity Prescription Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Anti-Obesity Prescription Drugs Price by Manufacturers
3.4 Key Manufacturers Anti-Obesity Prescription Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-Obesity Prescription Drugs Market
3.6 Key Manufacturers Anti-Obesity Prescription Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Orlistat Sales and Revenue (2015-2019)
4.1.2 Phentermine and Topiramate Sales and Revenue (2015-2019)
4.1.3 Bupropion and Naltrexone Sales and Revenue (2015-2019)
4.1.4 Lorcaserin Sales and Revenue (2015-2019)
4.1.5 Liraglutide Sales and Revenue (2015-2019)
4.2 Global Anti-Obesity Prescription Drugs Sales Market Share by Type
4.3 Global Anti-Obesity Prescription Drugs Revenue Market Share by Type
4.4 Anti-Obesity Prescription Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-Obesity Prescription Drugs Sales by Application
6 United States
6.1 United States Anti-Obesity Prescription Drugs Breakdown Data by Company
6.2 United States Anti-Obesity Prescription Drugs Breakdown Data by Type
6.3 United States Anti-Obesity Prescription Drugs Breakdown Data by Application
7 European Union
7.1 European Union Anti-Obesity Prescription Drugs Breakdown Data by Company
7.2 European Union Anti-Obesity Prescription Drugs Breakdown Data by Type
7.3 European Union Anti-Obesity Prescription Drugs Breakdown Data by Application
8 China
8.1 China Anti-Obesity Prescription Drugs Breakdown Data by Company
8.2 China Anti-Obesity Prescription Drugs Breakdown Data by Type
8.3 China Anti-Obesity Prescription Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-Obesity Prescription Drugs Breakdown Data by Company
9.2 Rest of World Anti-Obesity Prescription Drugs Breakdown Data by Type
9.3 Rest of World Anti-Obesity Prescription Drugs Breakdown Data by Application
9.4 Rest of World Anti-Obesity Prescription Drugs Breakdown Data by Countries
9.4.1 Rest of World Anti-Obesity Prescription Drugs Sales by Countries
9.4.2 Rest of World Anti-Obesity Prescription Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 F Hoffmann La Roche Ltd
10.1.1 F Hoffmann La Roche Ltd Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.1.4 Anti-Obesity Prescription Drugs Product Introduction
10.1.5 F Hoffmann La Roche Ltd Recent Development
10.2 Orexigen Therapeutics
10.2.1 Orexigen Therapeutics Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.2.4 Anti-Obesity Prescription Drugs Product Introduction
10.2.5 Orexigen Therapeutics Recent Development
10.3 Novo Nordisk A/s
10.3.1 Novo Nordisk A/s Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.3.4 Anti-Obesity Prescription Drugs Product Introduction
10.3.5 Novo Nordisk A/s Recent Development
10.4 Arena Pharmaceuticals
10.4.1 Arena Pharmaceuticals Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.4.4 Anti-Obesity Prescription Drugs Product Introduction
10.4.5 Arena Pharmaceuticals Recent Development
10.5 Glaxosmithkline
10.5.1 Glaxosmithkline Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.5.4 Anti-Obesity Prescription Drugs Product Introduction
10.5.5 Glaxosmithkline Recent Development
10.6 Vivus
10.6.1 Vivus Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.6.4 Anti-Obesity Prescription Drugs Product Introduction
10.6.5 Vivus Recent Development
10.7 Boehringer Ingelheim
10.7.1 Boehringer Ingelheim Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.7.4 Anti-Obesity Prescription Drugs Product Introduction
10.7.5 Boehringer Ingelheim Recent Development
10.8 Alizyme
10.8.1 Alizyme Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.8.4 Anti-Obesity Prescription Drugs Product Introduction
10.8.5 Alizyme Recent Development
12 Market Forecast
12.1 Global Anti-Obesity Prescription Drugs Sales and Revenue Forecast 2020-2025
12.2 Global Anti-Obesity Prescription Drugs Sales Forecast by Type
12.3 Global Anti-Obesity Prescription Drugs Sales Forecast by Application
12.4 Anti-Obesity Prescription Drugs Forecast by Regions
12.4.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Regions 2020-2025
12.4.2 Global Anti-Obesity Prescription Drugs Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.